Can-Fite -8.2% amid filing to offer units


Can-Fite BioPharma (NYSEMKT:CANF) is down 8.2% after hours following a filing to offer units.

Each unit will consist of one American Depositary Share and a warrant to purchase one ADS.

It’s also offering pre-funded units to those owners for whom purchasing units would raise ownership stakes beyond 4.99%.

The offering comes via H.C. Wainwright.





READ SOURCE

READ  PE deals, Ghosn in Beirut, the year of IPOs

LEAVE A REPLY

Please enter your comment!
Please enter your name here